APA (7th ed.) Citation

Taïeb, D., Tessonnier, L., Sebag, F., Niccoli-Sire, P., Morange, I., Colavolpe, C., . . . Mundler, O. (2008). The role of 18F-FDOPA and 18F-FDG–PET in the management of malignant and multifocal phaeochromocytomas. Clinical Endocrinology, 69(4), 580. https://doi.org/10.1111/j.1365-2265.2008.03257.x

Chicago Style (17th ed.) Citation

Taïeb, D., et al. "The Role of 18F-FDOPA and 18F-FDG–PET in the Management of Malignant and Multifocal Phaeochromocytomas." Clinical Endocrinology 69, no. 4 (2008): 580. https://doi.org/10.1111/j.1365-2265.2008.03257.x.

MLA (9th ed.) Citation

Taïeb, D., et al. "The Role of 18F-FDOPA and 18F-FDG–PET in the Management of Malignant and Multifocal Phaeochromocytomas." Clinical Endocrinology, vol. 69, no. 4, 2008, p. 580, https://doi.org/10.1111/j.1365-2265.2008.03257.x.